Avastin for PDR (Proliferative Diabetic Retinopathy)
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of anti-VEGF drug (Avastin)
adminstration in eyes prior to surgical treatment for Traction retinal detachment (TRD) in
patients with Proliferative Diabetic Retinopathy (PDR).